EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Risk of progression to type 2 diabetes or regression to normoglycaemia among Ghanaians with prediabetes living in Ghana and the Netherlands: The RODAM prospective study

Emmanuel Bannerman-Williams, Yacoba Atiase, Bert-Jan H van den Born, Felix Patience Chilunga iD, Eva van der Linden, Karlijn A C Meeks, Erik Beune, Charles Agyemang, Charles Frederick Hayfron-Benjamin iD

Diabetic Medicine · 2026

DOI: 10.1111/dme.70332 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetic Medicine, 2026. Verfasst von Emmanuel Bannerman-Williams und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health, Amsterdam UMC, University of Amsterdam, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Prediabetic State. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: European Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Evidence shows that ethnicity affects the risk of progression of prediabetes to type 2 diabetes(T2D) or regression to normoglycaemia However, little is known about progression rates among sub‐Saharan African populations or whether geographical context affects risk variations. We compared the risk of progression to T2D or regression to normoglycemia in West Africans with prediabetes living in Africa and their migrant compatriots living in Europe.

Methods

We analysed data from 615 Ghanaians with prediabetes at baseline (245 in Ghana/370 in Amsterdam) in the prospective RODAM cohort with an average follow‐up of 6.7 years. Prediabetes was defined according to the WHO criteria. Incidence risk ratios for progression to T2D and regression to normoglycaemia were calculated with adjustment for age, sex, follow‐up duration, socioeconomic status and baseline BMI and fasting plasma glucose.

Results

Overall, the cumulative incidences of T2D and normoglycaemia from prediabetes were 12.6% and 28.9%, respectively. While the proportions of individuals who progressed to T2D did not differ between non‐migrants and migrants (16.0% vs. 10.9%, p ‐value = 0.108), the proportion who regressed to normoglycaemia was higher in non‐migrants (51.5% vs. 17.1%, p < 0.001) with an incident risk ratio of 3.48 (95% CI 2.39–5.05, p < 0.001) in the fully adjusted model. However, the risk of progression of prediabetes to T2D remained similar in the two groups after full adjustment [1.20 (0.71–2.05), 0.498].

Conclusions

Among Ghanaians with prediabetes, regression to normoglycaemia was more frequent than progression to T2D, and more likely in non‐migrants than in migrants. Future studies could identify factors underlying the higher rates of regression to normoglycaemia in non‐migrants to improve outcomes in individuals with prediabetes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Prediabetic StateHumansGhanaMaleDisease ProgressionFemaleProspective StudiesNetherlandsMiddle AgedRisk FactorsIncidenceAdultBlood GlucoseWest African PeopleFollow-Up Studies

Stichwörter der Autor:innen

migrationprediabetes or intermediate hyperglycaemiasub‐Saharan Africanstype 2 diabetes

Substanzen

Blood Glucose

Autor:innen und Institutionen

  • Department of Public Health, Amsterdam UMC, University of Amsterdam, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands.
  • Department of Internal and Vascular Medicine, Amsterdam UMC, University of Amsterdam, Cardiovascular Sciences, Amsterdam, The Netherlands.
  • Department of Surgery, University of Ghana Medical School, Accra, Ghana.
  • Department of Medicine and Therapeutics, University of Ghana Medical School, National Diabetes Management & Research Center, Accra, Ghana.
  • Center for Research on Genomics and Global Health, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Division of Endocrinology, Diabetes and Nutrition, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.

ORCID-Profile: Felix Patience Chilunga, Charles Frederick Hayfron-Benjamin

Förderung

  • European Commission

Zitieren

APA

Bannerman-Williams, E., Atiase, Y., van den Born, B. H., Chilunga, F. P., van der Linden, E., Meeks, K. A. C., Beune, E., Agyemang, C., & Hayfron-Benjamin, C. F. (2026). Risk of progression to type 2 diabetes or regression to normoglycaemia among Ghanaians with prediabetes living in Ghana and the Netherlands: The RODAM prospective study. Diabetic Medicine. https://doi.org/10.1111/dme.70332

Vancouver

Bannerman-Williams E, Atiase Y, van den Born BH, Chilunga FP, van der Linden E, Meeks KAC, et al. Risk of progression to type 2 diabetes or regression to normoglycaemia among Ghanaians with prediabetes living in Ghana and the Netherlands: The RODAM prospective study. Diabetic Medicine. 2026. doi:10.1111/dme.70332

BibTeX
@article{BannermanWilliams2026,
  author = {Bannerman-Williams, Emmanuel and Atiase, Yacoba and van den Born, Bert-Jan H and Chilunga, Felix Patience and van der Linden, Eva and Meeks, Karlijn A C and Beune, Erik and Agyemang, Charles and Hayfron-Benjamin, Charles Frederick},
  title = {Risk of progression to type 2 diabetes or regression to normoglycaemia among Ghanaians with prediabetes living in Ghana and the Netherlands: The RODAM prospective study},
  journal = {Diabetic Medicine},
  year = {2026},
  doi = {10.1111/dme.70332}
}
Kostenlos starten →